Skip to main content

Investor Relations Home

 
Corporate Profile

HeartWare International Inc. is a global medical device company dedicated to delivering safe, high-performing and transformative therapies that enable patients with heart failure to get back to life. The company’s innovative technologies are creating advances in the miniaturization of Ventricular Assist Devices (VADs) leading to less invasive surgical procedures and increasing the patient population who may be suitable for VAD therapy.

Read More >>
Stock Quote

Medtronic to Expand Heart Failure Portfolio With Acquisition of HeartWare International

News release: Medtronic to Expand Heart Failure Portfolio with Acquisition of HeartWare International
Form 8-K: Agreement and Plan of Merger
Form SC TO-C: Notice of Noteholder Right to Convert / HeartWare International Notice to Noteholders

Upcoming EventsMore Events >>
DateTitle
08/10/16
through
08/11/16
Canaccord Genuity 36th Annual Growth Conference
LocationBoston, MA
09/07/16
through
09/08/16
Wells Fargo Securities Healthcare Conference
LocationBoston, MA

Recent NewsNews Releases >>ASX Announcements >>
DateTitle 
06/27/16Medtronic to Expand Heart Failure Portfolio with Acquisition of HeartWare InternationalPrinter Friendly Version
06/01/16HeartWare Presentation At The Goldman Sachs 37th Annual Global Healthcare Conference To Be WebcastPrinter Friendly Version
05/05/16HeartWare Presentation At The Bank Of America Merrill Lynch 2016 Health Care Conference To Be WebcastPrinter Friendly Version
05/04/16HeartWare International Reports First Quarter 2016 Financial ResultsPrinter Friendly Version

Featured ReportsMore Reports >>
Title
 PDF2015 Annual Report
 PDFHeartWare Ventricular Assist System - Instructions for Use

ISHLT 35th Annual Meeting and Scientific Sessions


ISHLT 2015 Opening Plenary Session
HeartWare HVAD for the Treatment of Patients with Advanced Heart Failure Ineligible for Cardiac Transplantation: Results of the ENDURANCE Destination Therapy Trial

Thursday, April 16, 2015 3:50 a.m. ET / 9:50 a.m. CET
LocationThe Acropolis Congress Centre, Apollon room
Nice, France
 
Download Event Supporting Material ISHLT 2015 Opening Plenary Session
Add to Calendar Add ISHLT 2015 Opening Plenary Session to Calendar  Help


HeartWare Lunch Symposium: Deeper Dive into HeartWare Clinical and Real-world Results

Thursday, April 16, 2015 6:45 a.m. ET / 12:45 p.m. CET
LocationThe Acropolis Congress Centre, Clio/Thalie room
Nice, France
Webcast
Click here for webcast
Add to Calendar Add HeartWare Lunch Symposium:  Deeper Dive into HeartWare Clinical and Real-world Results to Calendar  Help


HeartWare Investor Meeting Breakout Session

Thursday, April 16, 2015 9:00 a.m. ET / 3:00 p.m. CET
LocationThe Acropolis Congress Centre, room Gallieni 4
Nice, France
Webcast
Click here for webcast
 
Download Event Supporting Material HeartWare Investor Meeting Breakout Session
Add to Calendar Add HeartWare Investor Meeting Breakout Session to Calendar  Help


HeartWare and Valtech Cardio, Ltd. Announce Termination of HeartWare’s Proposed Acquisition of Valtech

On Jan. 28, 2016, HeartWare and Valtech Cardio, Ltd. announced termination of previously proposed acquisition.

For more information >>